Cargando…
Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309134/ https://www.ncbi.nlm.nih.gov/pubmed/35731338 http://dx.doi.org/10.1007/s12325-022-02213-2 |
| _version_ | 1784753091534389248 |
|---|---|
| author | Calzetta, Luigino Rogliani, Paola |
| author_facet | Calzetta, Luigino Rogliani, Paola |
| author_sort | Calzetta, Luigino |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9309134 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93091342022-07-26 Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab” Calzetta, Luigino Rogliani, Paola Adv Ther Letter Springer Healthcare 2022-06-22 2022 /pmc/articles/PMC9309134/ /pubmed/35731338 http://dx.doi.org/10.1007/s12325-022-02213-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter Calzetta, Luigino Rogliani, Paola Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab” |
| title | Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab” |
| title_full | Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab” |
| title_fullStr | Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab” |
| title_full_unstemmed | Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab” |
| title_short | Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab” |
| title_sort | letter to the editor regarding “clinical remission in severe asthma: a pooled post hoc analysis of the patient journey with benralizumab” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309134/ https://www.ncbi.nlm.nih.gov/pubmed/35731338 http://dx.doi.org/10.1007/s12325-022-02213-2 |
| work_keys_str_mv | AT calzettaluigino lettertotheeditorregardingclinicalremissioninsevereasthmaapooledposthocanalysisofthepatientjourneywithbenralizumab AT roglianipaola lettertotheeditorregardingclinicalremissioninsevereasthmaapooledposthocanalysisofthepatientjourneywithbenralizumab |